TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-2.75%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.85B
AUM Growth
+$2.85B
(-8.4%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
35.96%
Holding
185
New
14
Increased
26
Reduced
25
Closed
10
Top Buys
| 1 |
AstraZeneca
AZN
|
$13.5M |
| 2 |
Stryker
SYK
|
$11.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$9.35M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$8.6M |
| 5 |
Becton Dickinson
BDX
|
$8.15M |
Top Sells
| 1 |
Moderna
MRNA
|
$37.6M |
| 2 |
Thermo Fisher Scientific
TMO
|
$32.3M |
| 3 |
Merck
MRK
|
$17.4M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$16.4M |
| 5 |
Danaher
DHR
|
$15.3M |
Sector Composition
| 1 | Healthcare | 95.64% |
| 2 | Real Estate | 3.21% |
| 3 | Industrials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Elevance Health
ELV
$72.4B
| $7.19M | 0.25% |
14,644
| – | – |
|
77
Denali Therapeutics
DNLI
$2.24B
| $7.16M | 0.25% |
222,420
| – | – |
|
|
LTC
78
LTC Properties
LTC
$1.67B
| $7.01M | 0.25% |
182,293
| – | – |
|
79
HealthEquity
HQY
$8.26B
| $6.97M | 0.24% |
+103,314
| New | +$6.97M |
|
|
MRTX
80
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.89M | 0.24% |
83,784
| – | – |
|
81
Ionis Pharmaceuticals
IONS
$9.64B
| $6.51M | 0.23% |
175,680
| – | – |
|
82
Caribou Biosciences
CRBU
$176M
| $6.42M | 0.23% |
699,377
| – | – |
|
83
AMN Healthcare
AMN
$760M
| $6.39M | 0.22% |
61,201
| – | – |
|
84
Travere Therapeutics
TVTX
$1.75B
| $6.38M | 0.22% |
247,678
+34,809
| +16% | +$897K |
|
85
Sanofi
SNY
$122B
| $6.34M | 0.22% |
123,454
| – | – |
|
|
BPMC
86
DELISTED
Blueprint Medicines
BPMC
| $6.21M | 0.22% |
+97,253
| New | +$6.21M |
|
87
Arrowhead Research
ARWR
$3.84B
| $6.2M | 0.22% |
134,812
| – | – |
|
88
Revvity
RVTY
$9.68B
| $5.84M | 0.2% |
33,444
| – | – |
|
89
Smith & Nephew
SNN
$16.2B
| $5.8M | 0.2% |
181,710
| – | – |
|
90
Arvinas
ARVN
$580M
| $5.79M | 0.2% |
85,997
| – | – |
|
|
RCM
91
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.42M | 0.19% |
202,351
| – | – |
|
92
Qiagen
QGEN
$10.1B
| $5.29M | 0.19% |
107,855
| – | – |
|
93
Healthpeak Properties
DOC
$12.3B
| $5.16M | 0.18% |
150,392
| – | – |
|
94
Philips
PHG
$25.8B
| $5.03M | 0.18% |
164,790
| – | – |
|
95
Alkermes
ALKS
$4.95B
| $5M | 0.18% |
190,122
-87,187
| -31% | -$2.29M |
|
96
Acadia Healthcare
ACHC
$2.15B
| $4.74M | 0.17% |
+72,307
| New | +$4.74M |
|
97
Novavax
NVAX
$1.2B
| $4.7M | 0.17% |
63,800
| – | – |
|
98
Adaptive Biotechnologies
ADPT
$1.96B
| $4.69M | 0.16% |
337,722
| – | – |
|
99
Cytokinetics
CYTK
$5.98B
| $4.41M | 0.16% |
119,898
+27,027
| +29% | +$995K |
|
100
Teva Pharmaceuticals
TEVA
$21.5B
| $4.32M | 0.15% |
459,651
| – | – |
|